Related references
Note: Only part of the references are listed.Treatment of transplant kidneys during machine perfusion
Sarah A. Hosgood et al.
TRANSPLANT INTERNATIONAL (2021)
CMV-encoded GPCR pUL33 activates CREB and facilitates its recruitment to the MIE locus for efficient viral reactivation
Benjamin A. Krishna et al.
JOURNAL OF CELL SCIENCE (2021)
Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection
Nicole N. Haese et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention
Ian J. Groves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Advances in the Development of Therapeutics for Cytomegalovirus Infections
Edward Acosta et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Cell signaling and cytomegalovirus reactivation: what do Src family kinases have to do with it?
Matthew B. Reeves
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion
R. VP Ribeiro et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
Li Ding et al.
STEM CELL RESEARCH & THERAPY (2020)
Measuring the Success of HIV-1 Cure Strategies
Jordan Thomas et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Tuning the Orchestra: HCMV vs. Innate Immunity
Valentina Dell'Oste et al.
FRONTIERS IN MICROBIOLOGY (2020)
Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off?
Ian J. Groves et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
Yu-Qing Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
The Role of the Human CytomegalovirusUL133-UL138Gene Locus in Latency and Reactivation
Luwanika Mlera et al.
VIRUSES-BASEL (2020)
Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation
Terrance J. Y. Ku et al.
EBIOMEDICINE (2020)
Regulation of the MIE Locus During HCMV Latency and Reactivation
Abigail L. Dooley et al.
PATHOGENS (2020)
Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant
Terri Lynn Shigle et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)
HCMV latency: what regulates the regulators?
Elizabeth Elder et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2019)
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion
Marcos Galasso et al.
NATURE COMMUNICATIONS (2019)
Control of viral infections by epigenetic-targeted therapy
Zeina Nehme et al.
CLINICAL EPIGENETICS (2019)
HIV shock and kill therapy: In need of revision
Erik Abner et al.
ANTIVIRAL RESEARCH (2019)
Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter
Liane Dupont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation
Johan Maertens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Advances in the treatment of cytomegalovirus
B. A. Krishna et al.
BRITISH MEDICAL BULLETIN (2019)
Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency
Jason Buehler et al.
PLOS PATHOGENS (2019)
Monocytes Latently Infected with Human Cytomegalovirus Evade Neutrophil Killing
Elizabeth Elder et al.
ISCIENCE (2019)
Cytomegalovirus: Shape-Shifting the Immune System
Gaelle Picarda et al.
JOURNAL OF IMMUNOLOGY (2018)
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing
Miri Shnayder et al.
MBIO (2018)
Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
Donna Collins-McMillen et al.
VIRUSES-BASEL (2018)
Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation following Posttranscriptional Establishment of Latency
Eleonora Forte et al.
MBIO (2018)
Human Organ-Specific Endothelial Cell Heterogeneity
Raluca Marcu et al.
ISCIENCE (2018)
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
Julie H. Ishida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Congenital cytomegalovirus - who, when, what-with and why to treat?
Yinru Lim et al.
JOURNAL OF INFECTION (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency
Shu Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection
Benjamin A. Krishna et al.
MBIO (2017)
Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
B. A. Krishna et al.
NATURE COMMUNICATIONS (2017)
Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva
Marianne Leruez-Ville et al.
CLINICAL INFECTIOUS DISEASES (2017)
Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency
Roberto Alfonso-Dunn et al.
CELL HOST & MICROBE (2017)
Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells
Monica S. Humby et al.
JOURNAL OF VIROLOGY (2016)
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
Firas El Chaer et al.
BLOOD (2016)
Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency
Song Hee Lee et al.
JOURNAL OF VIROLOGY (2016)
Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art
Ana Bela Campos et al.
REVIEWS IN MEDICAL VIROLOGY (2016)
Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
Timothy K. Tippin et al.
THERAPEUTIC DRUG MONITORING (2016)
Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication
Jason Buehler et al.
PLOS PATHOGENS (2016)
Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells
B. A. Krishna et al.
SCIENTIFIC REPORTS (2016)
Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo
Katja Spiess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch
Benjamin Rauwel et al.
ELIFE (2015)
Universal Prophylaxis or Preemptive Strategy for Cytomegalovirus Disease After Liver Transplantation: A Systematic Review and Meta-Analysis
K. Mumtaz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
A High-Affinity Native Human Antibody Neutralizes Human Cytomegalovirus Infection of Diverse Cell Types
Lawrence M. Kauvar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
Mark R. Wills et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
The pathogenesis of human cytomegalovirus
Paul Griffiths et al.
JOURNAL OF PATHOLOGY (2015)
Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients
G. Venton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Mechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activity
Han Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency
Verity G. Kew et al.
PLOS PATHOGENS (2014)
Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency
Franziska Dag et al.
PLOS PATHOGENS (2014)
The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model
Jutte J. C. de Vries et al.
REVIEWS IN MEDICAL VIROLOGY (2013)
Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection
Michael P. Weekes et al.
SCIENCE (2013)
Targeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactivation from Latency
Yu Liang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Regulation of Human Cytomegalovirus Transcription in Latency: Beyond the Major Immediate-Early Promoter
Matthew Reeves et al.
VIRUSES-BASEL (2013)
Cis and Trans Acting Factors Involved in Human Cytomegalovirus Experimental and Natural Latent Infection of CD14 (+) Monocytes and CD34 (+) Cells
Cyprian C. Rossetto et al.
PLOS PATHOGENS (2013)
Ex vivo lung perfusion (EVLP)
Marcelo Cypel
CURRENT PULMONOLOGY REPORTS (2013)
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
S. F. Atabani et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein
Koen Bartholomeeusen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Attribution of Congenital Cytomegalovirus Infection to Primary Versus Non-Primary Maternal Infection
Chengbin Wang et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Latency-Associated UL138 Gene Product of Human Cytomegalovirus Sensitizes Cells to Tumor Necrosis Factor Alpha (TNF-α) Signaling by Upregulating TNF-α Receptor 1 Cell Surface Expression
Christina Montag et al.
JOURNAL OF VIROLOGY (2011)
The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
Thomas Goldner et al.
JOURNAL OF VIROLOGY (2011)
Human cytomegalovirus immunity and immune evasion
Sarah E. Jackson et al.
VIRUS RESEARCH (2011)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection
John Sinclair
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter
Matthew B. Reeves et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Management of cytomegalovirus infection in solid organ transplantation
Camille N. Kotton
NATURE REVIEWS NEPHROLOGY (2010)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Michael J. Cannon et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy
B. George et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune Population
Marisa M. Mussi-Pinhata et al.
CLINICAL INFECTIOUS DISEASES (2009)
Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and Reactivation
Christof K. Seckert et al.
JOURNAL OF VIROLOGY (2009)
Functional Repair of Human Donor Lungs by IL-10 Gene Therapy
Marcelo Cypel et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions
Martin Michaelis et al.
NEOPLASIA (2009)
Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessment
Scott D. Grosse et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection
Giuseppe Gerna et al.
JOURNAL OF GENERAL VIROLOGY (2008)
CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis
Nikolaos Bonaros et al.
CLINICAL TRANSPLANTATION (2008)
Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis
Minoo Battiwalla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Phenotypic heterogeneity of the endothelium I. Structure, function, and mechanisms
William C. Aird
CIRCULATION RESEARCH (2007)
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection
Sheila C. Dollard et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet
W. Lawrence Drew et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Maribavir antagonizes the antiviral action of ganciclovir on human cytomegalovirus
Sunwen Chou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling
MB Reeves et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers
MB Reeves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee
AM Arvin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Pharmacokinetics of oral valganciclovir and intravenous ganciclovir administered to prevent cytomegalovirus disease in an adult patient receiving small-intestine transplantation
JF Abete et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in Vivo
MB Reeves et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Role of tumor necrosis factor-α in graft-versus-host disease and graft-versus-leukemia responses
R Korngold et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor
P Casarosa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency
FD Goodrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Ganciclovir-resistant cytomegalovirus in organ transplant recipients
AP Limaye
CLINICAL INFECTIOUS DISEASES (2002)
Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype
N Khan et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.
SB Boppana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients
MD Pescovitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
